Biomarin Pharmaceutical Stock Forecast - Daily Balance Of Power
| BMRN Stock | USD 64.34 0.15 0.23% |
Biomarin Stock Forecast is based on your current time horizon. Although Biomarin Pharmaceutical's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Biomarin Pharmaceutical's systematic risk associated with finding meaningful patterns of Biomarin Pharmaceutical fundamentals over time.
Biomarin |
Open Interest Against 2025-04-17 Biomarin Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Biomarin Pharmaceutical's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Biomarin Pharmaceutical's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Biomarin Pharmaceutical stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Biomarin Pharmaceutical's open interest, investors have to compare it to Biomarin Pharmaceutical's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Biomarin Pharmaceutical is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Biomarin. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
| Previous Daily Balance Of Power | Daily Balance Of Power | Trend |
| 0.4192 | (0.51) |
| Check Biomarin Pharmaceutical Volatility | Backtest Biomarin Pharmaceutical | Trend Details |
Biomarin Pharmaceutical Trading Date Momentum
| On December 29 2023 Biomarin Pharmaceutical was traded for 96.42 at the closing time. The top price for the day was 97.43 and the lowest listed price was 96.10 . The trading volume for the day was 630.3 K. The trading history from December 29, 2023 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.73% . The overall trading delta against the current closing price is 0.70% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
| Compare Biomarin Pharmaceutical to competition |
Other Forecasting Options for Biomarin Pharmaceutical
For every potential investor in Biomarin, whether a beginner or expert, Biomarin Pharmaceutical's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Biomarin Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Biomarin. Basic forecasting techniques help filter out the noise by identifying Biomarin Pharmaceutical's price trends.View Biomarin Pharmaceutical Related Equities
| Risk & Return | Correlation |
Biomarin Pharmaceutical Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Biomarin Pharmaceutical's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Biomarin Pharmaceutical's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Biomarin Pharmaceutical Market Strength Events
Market strength indicators help investors to evaluate how Biomarin Pharmaceutical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biomarin Pharmaceutical shares will generate the highest return on investment. By undertsting and applying Biomarin Pharmaceutical stock market strength indicators, traders can identify Biomarin Pharmaceutical entry and exit signals to maximize returns.
| Accumulation Distribution | 14844.58 | |||
| Daily Balance Of Power | 0.1786 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 64.29 | |||
| Day Typical Price | 64.31 | |||
| Price Action Indicator | 0.13 | |||
| Period Momentum Indicator | 0.15 |
Biomarin Pharmaceutical Risk Indicators
The analysis of Biomarin Pharmaceutical's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Biomarin Pharmaceutical's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting biomarin stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.13 | |||
| Standard Deviation | 1.57 | |||
| Variance | 2.46 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
When determining whether Biomarin Pharmaceutical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biomarin Pharmaceutical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biomarin Pharmaceutical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biomarin Pharmaceutical Stock: Check out Historical Fundamental Analysis of Biomarin Pharmaceutical to cross-verify your projections. To learn how to invest in Biomarin Stock, please use our How to Invest in Biomarin Pharmaceutical guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomarin Pharmaceutical. If investors know Biomarin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomarin Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.607 | Earnings Share 1.66 | Revenue Per Share | Quarterly Revenue Growth 0.283 | Return On Assets |
The market value of Biomarin Pharmaceutical is measured differently than its book value, which is the value of Biomarin that is recorded on the company's balance sheet. Investors also form their own opinion of Biomarin Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Biomarin Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomarin Pharmaceutical's market value can be influenced by many factors that don't directly affect Biomarin Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomarin Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomarin Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomarin Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.